DFX Intelligence

Data Factory

RIA / WealthPrivate fundventure capital fund3(c)(1)

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

California, United States

This is the graph view. The full profile, with its team, deals and sources, is on RIA / Wealth Management.Open the full profile →

Search this name across graphsid dfx:ria:49d54e6b-af29-b72d-c0dc-bf2081475e3a

Data as of Apr 3, 2023 (this record's last observation) from federal regulator filings. Page built Sep 20, 2026, 10:01 AM UTC and rebuilt at most every 15 minutes.

Relationships: 0
Dated events: 0
On other graphs: 1
Observed: Mar 30, 2012 to Apr 3, 2023
15 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Venture Capitalidentity

Sanderling IV Biomedical Co-Investment Fund, L.P.

Venture fund · shared adv fund id

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Fund type: Venture Capital Fund
Latest reported GAV: $207,505gross asset value on Schedule D 7.B(1), as of 2023-04-03; never fund size
Peak reported GAV: $2.9M
Beneficial owners: 5
Minimum investment: $1
Owned by the adviser: 100%
Owned by funds of funds: 9900%
Owned by non-US persons: 1100%
Clients solicited: no
Organised in: California, United States
First reported: Mar 30, 2012
Last reported: Apr 3, 2023fund reporting on the SEC extract ends 2024-12-31
Filings reporting it: 15
Fund id: 805-5946695941

Reported gross asset value by filing

each Schedule D 7.B(1) row as filed; GAV is gross asset value, never fund size

Filed	GAV	Owners	Minimum	Adviser owns	Audited	Name as filed
Apr 3, 2023	$207,505	5	$1	100.0%	no	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Apr 4, 2022	$220,294	5	$1	100.0%	no	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Mar 31, 2021	$243,845	4	$1	100.0%	no	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Apr 29, 2020	$251,815	4	$1	100.0%	no	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Mar 28, 2019	$269,088	4	$1	100.0%	no	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Apr 2, 2018	$470,372	4	$1	100.0%	no	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Feb 5, 2018	$149,248	4	$1	100.0%	yes	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Jan 29, 2018	$149,248	4	$1	100.0%	yes	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Mar 21, 2017	$149,248	4	$1	100.0%	no	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Mar 21, 2016	$587,422	4	$1	100.0%	no	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Mar 26, 2015	$475,691	4	$1	100.0%	no	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Mar 28, 2014	$648,398	4	$1	100.0%	no	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Mar 27, 2013	$1.1M	4	$1	100.0%	no	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Oct 25, 2012	$2.9M	4	$1	100.0%	no	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.
Mar 30, 2012	$2.9M	4	$1	100.0%	no	SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Custodians

Schedule D 7.B(1) question 25, as filed

Custodian	Legal name	City	State	Country	Related person	SEC number
RBC CAPITAL MARKETS, LLC	RBC CAPITAL MARKETS, LLC	SAN FRANCISCO	California	United States	no	8-45411
SILICON VALLEY BANK	SILICON VALLEY BANK	SANTA CLARA	California	United States	no	n/a

Relationships

No published relationship touches this entity yet.

Dated events

No dated event names this entity yet.

Provenance

Graph: RIA / Wealth Management
Canonical id: dfx:ria:49d54e6b-af29-b72d-c0dc-bf2081475e3a
First observed: Mar 30, 2012
Last observed: Apr 3, 2023 42 months ago
Source families: Federal regulator filings
1 registered feed stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

California, United States

This is the graph view. The full profile, with its team, deals and sources, is on RIA / Wealth Management.Open the full profile →

Search this name across graphsid dfx:ria:49d54e6b-af29-b72d-c0dc-bf2081475e3a

Data as of Apr 3, 2023 (this record's last observation) from federal regulator filings. Page built Sep 20, 2026, 10:01 AM UTC and rebuilt at most every 15 minutes.

Filed

GAV

Owners

Minimum

Adviser owns

Audited

Name as filed

Apr 3, 2023

$207,505

100.0%

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Apr 4, 2022

$220,294

100.0%

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Mar 31, 2021

$243,845

100.0%

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Apr 29, 2020

$251,815

100.0%

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Mar 28, 2019

$269,088

100.0%

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Apr 2, 2018

$470,372

100.0%

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Feb 5, 2018

$149,248

100.0%

yes

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Jan 29, 2018

$149,248

100.0%

yes

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Mar 21, 2017

$149,248

100.0%

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Mar 21, 2016

$587,422

100.0%

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Mar 26, 2015

$475,691

100.0%

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Mar 28, 2014

$648,398

100.0%

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Mar 27, 2013

$1.1M

100.0%

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Oct 25, 2012

$2.9M

100.0%

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Mar 30, 2012

$2.9M

100.0%

SANDERLING IV BIOMEDICAL CO-INVESTMENT FUND, L.P.

Custodian

Legal name

City

State

Country

Related person

SEC number

RBC CAPITAL MARKETS, LLC

SAN FRANCISCO

California

United States

8-45411

SILICON VALLEY BANK

SANTA CLARA

California

United States

n/a